Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX)

Historical Holders from Q1 2019 to Q3 2024

Symbol
FBRX on Nasdaq
CUSIP
34962G109
Type / Class
Equity / Common Stock, par value $0.001 per share (the "Shares")
Shares outstanding
6.5M
All holders as of September 30, 2024
Q3 2024
Shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-31
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Farallon Capital Partners, L.P. 3.4% $12.1K 221K Dapice Joshua J. Dec 31, 2024

Institutional Holders of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (the "Shares") (FBRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$10.1M 0
2024 Q2 19M $10.2M -$6.92K $0.54 31
2024 Q1 19M $13.3M +$132K $0.70 32
2023 Q4 18.9M $15.5M +$108K $0.82 31
2023 Q3 16.7M $11.1M +$8.68M $0.66 29
2023 Q2 3.46M $3.6M -$406K $1.04 28
2023 Q1 3.87M $3.9M +$63.5K $1.01 28
2022 Q4 3.8M $3.8M -$332K $1.00 29
2022 Q3 2.67M $2.85M +$304K $1.07 23
2022 Q2 1.97M $2.56M -$1.85M $1.30 26
2022 Q1 3.45M $5.04M -$1.51M $1.46 43
2021 Q4 5.36M $11.5M +$2.61M $2.14 44
2021 Q3 3.88M $12.7M -$210M $2.96 53
2021 Q2 8.61M $289M +$18M $33.62 75
2021 Q1 7.97M $273M -$15.1M $34.27 62
2020 Q4 7.95M $289M +$46.1M $36.41 48
2020 Q3 6.8M $330M +$190M $48.51 41
2020 Q2 2.88M $42M +$42M $14.58 23
2020 Q1 66 $2K $0 $30.30 1
2019 Q4 66 $2K $0 $30.30 1
2019 Q3 66 $2K $0 $30.30 1
2019 Q2 66 $2K $0 $30.30 1
2019 Q1 66 $2K $0 $30.30 1